We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Dermatologic Immunotherapy

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Dermatology
Observation  | 
Treatment of Refractory Pityriasis Rubra Pilaris With Novel Phosphodiesterase 4 (PDE4) Inhibitor Apremilast
Ifat Zerin Krase, PharmD; Kevin Cavanaugh, MD; Clara Curiel-Lewandrowski, MD
JAMA Dermatology
Case Report/Case Series  | 
Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa
Tania M.  Gonzalez Santiago, MD; Andrey Zavialov, PhD; Janna Saarela, MD, PhD; et al.
JAMA Dermatology
Observation  | 
BRAF Inhibition in a Lung Transplant Recipient With Metastatic Melanoma
Kambiz Afshar, MD; Sascha David, MD; Thomas Fuehner, MD; et al.
JAMA Dermatology
Original Investigation  | 
Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab
Camille Hua, MD; Lise Boussemart, MD, PhD; Christine Mateus, MD; et al.